Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases

Yusof, YM, Arnold, J, Saleem, B et al. (5 more authors) (2022) Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases. In: Arthritis and Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 1559-1560.

Metadata

Authors/Creators:
Keywords: B-Lymphocyte, Biologicals, COVID-19, prognostic factors, rheumatoid arthritis
Dates:
  • Published (online): 29 September 2022
  • Published: 29 September 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Jun 2023 14:08
Last Modified: 14 Jun 2023 14:08
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/art.42355
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)